NO20012226D0 - Terapeutiske midler for medikamentavhengighet - Google Patents

Terapeutiske midler for medikamentavhengighet

Info

Publication number
NO20012226D0
NO20012226D0 NO20012226A NO20012226A NO20012226D0 NO 20012226 D0 NO20012226 D0 NO 20012226D0 NO 20012226 A NO20012226 A NO 20012226A NO 20012226 A NO20012226 A NO 20012226A NO 20012226 D0 NO20012226 D0 NO 20012226D0
Authority
NO
Norway
Prior art keywords
therapeutic agents
drug addiction
addiction
drug
therapeutic
Prior art date
Application number
NO20012226A
Other languages
English (en)
Other versions
NO321735B1 (no
NO20012226L (no
Inventor
Tsutomu Suzuki
Shiro Mita
Kiyoshi Matsuno
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of NO20012226D0 publication Critical patent/NO20012226D0/no
Publication of NO20012226L publication Critical patent/NO20012226L/no
Publication of NO321735B1 publication Critical patent/NO321735B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20012226A 1998-11-09 2001-05-04 Anvendelse av et piperazinderivat for fremstilling av et preventiv eller terapeutisk middel mot stoffavhengighet NO321735B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP31746898 1998-11-09
PCT/JP1999/006148 WO2000027833A1 (fr) 1998-11-09 1999-11-04 Medicaments contre la dependance aux drogues

Publications (3)

Publication Number Publication Date
NO20012226D0 true NO20012226D0 (no) 2001-05-04
NO20012226L NO20012226L (no) 2001-06-12
NO321735B1 NO321735B1 (no) 2006-06-26

Family

ID=18088576

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012226A NO321735B1 (no) 1998-11-09 2001-05-04 Anvendelse av et piperazinderivat for fremstilling av et preventiv eller terapeutisk middel mot stoffavhengighet

Country Status (9)

Country Link
US (1) US6492369B2 (no)
EP (1) EP1130018B1 (no)
KR (1) KR100700347B1 (no)
CN (1) CN1131221C (no)
CA (1) CA2349452C (no)
DE (1) DE69934902T2 (no)
ES (1) ES2281196T3 (no)
NO (1) NO321735B1 (no)
WO (1) WO2000027833A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2116539A1 (en) 2008-04-25 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
EP2353591A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof
EP2353598A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for use in the prevention and/or treatment of postoperative pain
EP2388005A1 (en) 2010-05-21 2011-11-23 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
EP2415471A1 (en) 2010-08-03 2012-02-08 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in opioid-induced hyperalgesia
EP2524694A1 (en) 2011-05-19 2012-11-21 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in diabetes type-2 associated pain
KR20160097366A (ko) 2013-12-17 2016-08-17 라보라토리오스 델 드라. 에스테브.에스.에이. 세로토닌-노르에피네프린 재흡수 억제제들(SNRIs) 및 시그마 리셉터 리간드들 조합

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5556857A (en) * 1991-05-08 1996-09-17 Otsuka Pharmaceutical Co., Ltd. Disturbance-of-consciousness improving agent
EP0591426A4 (en) * 1991-06-27 1996-08-21 Univ Virginia Commonwealth Sigma receptor ligands and the use thereof
CA2166100A1 (en) * 1993-06-23 1995-01-05 Richard A. Glennon Sigma receptor ligands and the use thereof
JP2883970B2 (ja) 1993-07-28 1999-04-19 参天製薬株式会社 新規１，４−（ジフェニルアルキル）ピペラジン誘導体
DE69426157T2 (de) * 1993-07-28 2001-05-17 Santen Pharmaceutical Co Ltd 1,4-di(phenylalkyl)piperazinderivate
JPH10120569A (ja) 1996-10-21 1998-05-12 Santen Pharmaceut Co Ltd 眼疾患予防または治療剤

Also Published As

Publication number Publication date
CN1325391A (zh) 2001-12-05
CN1131221C (zh) 2003-12-17
KR20010089413A (ko) 2001-10-06
NO321735B1 (no) 2006-06-26
EP1130018A4 (en) 2003-01-15
CA2349452A1 (en) 2000-05-18
DE69934902T2 (de) 2007-10-18
CA2349452C (en) 2009-02-10
EP1130018B1 (en) 2007-01-17
US6492369B2 (en) 2002-12-10
US20020019399A1 (en) 2002-02-14
NO20012226L (no) 2001-06-12
WO2000027833A1 (fr) 2000-05-18
EP1130018A1 (en) 2001-09-05
KR100700347B1 (ko) 2007-03-29
DE69934902D1 (de) 2007-03-08
ES2281196T3 (es) 2007-09-16

Similar Documents

Publication Publication Date Title
DK1637127T3 (da) Terapeutisk mikroskum
NO20021400D0 (no) Terapeutiske konazolinderivater
IS5760A (is) Meðferðarlegar bíarýl afleiður
ID23874A (id) Obat
NO20022692L (no) Terapeutiske midler
DE60040876D1 (de) Medikamentenzuführeinrichtung
GB9911863D0 (en) Therapeutic agents
NO20004196D0 (no) Innretninger for legemiddelavlevering
GB9905010D0 (en) Therapeutic agents
NO980546D0 (no) Farmasöytiske midler
GB9904786D0 (en) Therapeutic agents
GB9929685D0 (en) Therapeutic agents
NO20005179D0 (no) Medikament behandling
NO20015510D0 (no) Medikament for lokal påföring
GB9911881D0 (en) Therapeutic agents
GB9921351D0 (en) Therapeutic agents
GB9903476D0 (en) Therapeutic agents
GB9929569D0 (en) Therapeutic agents
NO20012226D0 (no) Terapeutiske midler for medikamentavhengighet
GB9914744D0 (en) Therapeutic agents
IS6163A (is) Lyfjakomplex
GB9903119D0 (en) Therapeutic agents
NO20016301D0 (no) Terapeutiske midler
GB9914745D0 (en) Therapeutic agents
GB9902881D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees